Orbital B-Lymphocyte Depletion in a Treatment Failure of Rituximab for Thyroid Eye Disease

被引：10

作者：

Gess, Adam J. ^{[1
]}

Silkiss, Rona Z. ^{[1
]}

机构：

[1] Calif Pacific Med Ctr, San Francisco, CA USA

来源：

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY | 2014年 / 30卷 / 01期

关键词：

CELL DEPLETION; GRAVES-DISEASE; OPHTHALMOPATHY; MECHANISM; ANTIBODY; THERAPY;

D O I：

10.1097/IOP.0b013e31828956a8

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Rituximab is an emerging treatment for thyroid eye disease. Rituximab effectively depletes circulating CD20+ B-lymphocytes; however, its effect on target tissues has not been well-studied. Failures of rituximab have been infrequently reported. The authors describe a patient treated with rituximab for thyroid eye disease who failed to respond to treatment, and underwent orbital decompression. Orbital fat samples and peripheral blood samples were evaluated for the presence of CD20+ B-lymphocytes. Complete depletion of CD20+ B-lymphocytes was demonstrated in both the orbit and the blood. This case demonstrates that rituximab effectively depletes orbital CD20+ B-lymphocytes, and this depletion was maintained for 2 months despite a clinical deterioration.

引用

页码：E11 / E13

页数：3

共 50 条

[1] Rituximab, B-Lymphocyte Depletion, and Beta-Cell Function
Nagafuchi, Seiho
Katsuta, Hitoshi
Anzai, Keizo
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08): : 761 - 761
[2] Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease
El Fassi, Daniel
Clemmensen, Ole
Nielsen, Claus H.
Silkiss, Rona Z.
Hegedues, Laszlo
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (10): : 3762 - 3763
[3] Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Pescovitz, Mark D.
Greenbaum, Carla J.
Krause-Steinrauf, Heidi
Becker, Dorothy J.
Gitelman, Stephen E.
Goland, Robin
Gottlieb, Peter A.
Marks, Jennifer B.
McGee, Paula F.
Moran, Antoinette M.
Raskin, Philip
Rodriguez, Henry
Schatz, Desmond A.
Wherrett, Diane
Wilson, Darrell M.
Lachin, John M.
Skyler, Jay S.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (22): : 2143 - 2152
[4] Alterations in stimulatory TSH receptor autoantibodies after B-lymphocyte depletion with rituximab in Graves' disease
El Fassi, D.
Gilbert, J. A.
Banga, J. P.
Nielsen, C. H.
Hegedus, L.
[J]. HORMONE RESEARCH, 2007, 68 : 61 - 61
[5] B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
Pescovitz, Mark D.
Greenbaum, Carla J.
Bundy, Brian
Becker, Dorothy J.
Gitelman, Stephen E.
Goland, Robin
Gottlieb, Peter A.
Marks, Jennifer B.
Moran, Antoinette
Raskin, Philip
Rodriguez, Henry
Schatz, Desmond A.
Wherrett, Diane K.
Wilson, Darrell M.
Krischer, Jeffrey P.
Skyler, Jay S.
[J]. DIABETES CARE, 2014, 37 (02) : 453 - 459
[6] Long-term B-lymphocyte depletion and remission of granulomatosis with polyangiitis after two courses of rituximab treatment
Valor-Mendez, Larissa
Kleyer, Arnd
Rech, Juergen
Manger, Bernhard
Schett, Georg
[J]. RHEUMATOLOGY, 2021, 60 (05) : E162 - E164
[7] Rituximab in the Treatment of Thyroid Eye Disease: A Review
Ostrowski, Rochella A.
Bussey, Melissa R.
Shayesteh, Yasmin
Jay, Walter M.
[J]. NEURO-OPHTHALMOLOGY, 2015, 39 (03) : 109 - 115
[8] Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion
Sato, Mai
Kamei, Koichi
Ogura, Masao
Ishikura, Kenji
Ito, Shuichi
[J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (01) : 110 - 116
[9] Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion
Mai Sato
Koichi Kamei
Masao Ogura
Kenji Ishikura
Shuichi Ito
[J]. Clinical and Experimental Nephrology, 2018, 22 : 110 - 116
[10] Rituximab in the Treatment of Thyroid Eye Disease: Science Fiction?
Salvi, Mario
Vannucchi, Guia
Campi, Irene
Beck-Peccoz, Paolo
[J]. ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2009, 28 (04): : 251 - 255

← 1 2 3 4 5 →